These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34332665)

  • 1. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
    Jackson LR; Jackson KP; Thomas KL
    Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
    Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
    Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
    Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
    Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
    Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a global registry to evaluate real-world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device-Perspective of available/ongoing registries of catheter-based LAA occlusion.
    Hildick-Smith D; Diener HC; Schmidt B; Paul V; Settergren M; Teiger E; Camm J; Tondo C; Landmesser U
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):540-547. PubMed ID: 28862376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
    Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B
    Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.
    Bergmann MW
    Trends Cardiovasc Med; 2017 Aug; 27(6):435-446. PubMed ID: 28461140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Left Atrial Appendage Exclusion Procedures to Reduce the Risk of Stroke: A Systematic Review of the Evidence.
    Noelck N; Papak J; Freeman M; Paynter R; Low A; Motu'apuaka M; Kondo K; Kansagara D
    Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):395-405. PubMed ID: 27407055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
    Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
    Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operator Experience and Outcomes after Transcatheter Left Atrial Appendage Occlusion with the Watchman Device.
    Sawant AC; Seibolt L; Sridhara S; Rodriguez J; Distler E; Murarka S; Lazkani M; Kumar A; Kanwar N; Prakash MPH; Wiesner P; Pershad A
    Cardiovasc Revasc Med; 2020 Apr; 21(4):467-472. PubMed ID: 31501020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous left atrial appendage occlusion in the current practice.
    Cruz-González I; Trejo-Velasco B
    Kardiol Pol; 2021 Mar; 79(3):255-268. PubMed ID: 33687872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.